NCT00617045

Duloxetine for the Treatment of Postpartum Depression

Duloxetine in the Treatment of Postpartum-onset and Non-Postpartum Onset Major Depressive Disorder

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Yale University · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.

Detailed description

Study was terminated because of poor enrollment

Conditions

• Postpartum Depression
• Major Depressive Disorder

Interventions

Type	Name	Description
DRUG	duloxetine	Total treatment period is 12 weeks 30mg po qd times 1 week 60mg po qd times 11 weeks

Timeline

• Start date: 2007-07-01
• Primary completion: 2012-12-01
• Completion: 2013-05-01
• First posted: 2008-02-15
• Last updated: 2016-06-17

Locations

1 site across 1 country: United States